South Korea · 
Who invested in PharmAbcine?
PharmAbcine's investors include OrbiMed, Novartis Venture Fund, Green Cross and Tong Yang Venture Capital.
South Korea · Series A startup
Who invested in PharmAbcine
One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$6.0Mraised across 1 round since 2009, from 1 source
- Latest round
- Series A, $6.0MSept 2009
- Investors
- 4
The rounds
- Sept 2009Series A$6.0M
Reported by bio-medicine.org
Everyone who backed them
Tong Yang Venture CapitalVC firm1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists PharmAbcine as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about PharmAbcine
How much has PharmAbcine raised?
PharmAbcine has raised $6.0M across 1 round since 2009.
When did PharmAbcine last raise?
PharmAbcine's most recent round was a Series A of $6.0M in Sept 2009.
What was PharmAbcine's biggest round?
Its most recent round, $6.0M in Sept 2009, is also its largest on record.
Who backed PharmAbcine first?
PharmAbcine's first round on record, in Sept 2009, was backed by OrbiMed, Novartis Venture Fund and Green Cross and 1 others.
What stage is PharmAbcine at?
PharmAbcine's latest named round is a Series A, in Sept 2009.
Where is PharmAbcine based?
PharmAbcine is based in South Korea.
Companies like PharmAbcine
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.